commercialization
-
In the midst of a market downturn, with a year-on-year sales increase of 50%, what did this biopharma do right?
A Biopharma with outstanding product innovation and internal adjustment capabilities has no reason not to navigate through the cycle
-
InnoCare Pharma: A Sample of Accelerated Commercialization for Biotech Companies
For Biotech to succeed, the key lies in how to balance R&D and commercialization while adhering to clinical needs as the foundation
-
Exchanging a CAR-T therapy for 18% of the shares, the decision-making of Innovent Biologics
All comments are highly welcome!
